» Authors » Kunikazu Tsuji

Kunikazu Tsuji

Explore the profile of Kunikazu Tsuji including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 115
Citations 2482
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamashita R, Nozawa I, Hasegawa S, Nakagawa Y, Miyatake K, Katagiri H, et al.
Biochem Biophys Res Commun . 2025 Jan; 749:151290. PMID: 39855042
C-type natriuretic peptide (CNP) can be a new disease-modifying anti-osteoarthritis drug (DMOAD) candidate because intraarticular injection of CNP attenuates both articular cartilage degradation and persistent pain in a rat knee...
2.
Kokabu S, Kodama N, Miyawaki A, Tsuji K, Hino J, Ono Y, et al.
Biochem Biophys Res Commun . 2025 Jan; 746():151261. PMID: 39742789
Bone morphogenetic protein (BMP)-3b, also known as growth differentiation factor (GDF)-10, belongs to the transforming growth factor (TGF)-β superfamily. Despite being named a BMP, BMP3b is considered as an intermediate...
3.
Tenger K, Komori K, Maehara A, Miyazaki K, Marukawa E, Yoshii T, et al.
BMC Musculoskelet Disord . 2024 Dec; 25(1):1048. PMID: 39702131
Background: The rapid decline in ovarian function associated with menopause promotes osteoclast differentiation and increases bone resorption, disrupting of bone homeostasis and increasing the risk of osteoporosis. Hyaluronic acid (HA)...
4.
Kodama N, Matsubara T, Yoshimura A, Nagano K, Hino J, Tsuji K, et al.
Bone . 2024 Oct; 190:117303. PMID: 39461491
Bone morphogenetic protein 3b (BMP3b), also known as growth differentiation factor 10 (GDF10), is a non-osteogenic BMP highly expressed in the skeleton. Although in vitro studies have shown that BMP3b...
5.
Hasegawa S, Yamashita R, Nakagawa Y, Miyatake K, Katagiri H, Nakamura T, et al.
Sci Rep . 2024 Jul; 14(1):16909. PMID: 39043741
The pain assessment in animals is challenging as they cannot verbally express the site and severity of pain. In this study, we tried a small implantable actimeter, "Nanotag", to monitor...
6.
Yoshida R, Koga H, Matsuda J, Nakamura T, Miyatake K, Katagiri H, et al.
Am J Sports Med . 2024 May; 52(7):1784-1793. PMID: 38721771
Background: The vancomycin presoaking technique (wherein grafts are treated with a vancomycin solution [VS] for anterior cruciate ligament reconstruction [ACLR]) reduces the infection rate after ACLR. However, the effects of...
7.
Yang Y, Koga H, Nakagawa Y, Nakamura T, Katagiri H, Takada R, et al.
Arthritis Res Ther . 2024 Jan; 26(1):17. PMID: 38200556
Background: Variations in bone morphology in patients with hip osteoarthritis (HOA) can be broadly categorized into three types: atrophic, normotrophic, and hypertrophic. Despite the investigations examining clinical elements, such as...
8.
Qian C, Ito N, Tsuji K, Sato S, Kikuchi K, Yoshii T, et al.
FEBS Open Bio . 2023 Dec; 14(2):290-299. PMID: 38050660
Congenital fibroblast growth factor 23 (FGF23)-related hypophosphatemic rickets/osteomalacia is a rare bone metabolism disorder characterized by hypophosphatemia and caused by genetic abnormalities that result in excessive secretion of FGF23. Hyp...
9.
Ling Z, Aini H, Kajikawa S, Shirakawa J, Tsuji K, Asou Y, et al.
Pharmaceuticals (Basel) . 2023 Oct; 16(10). PMID: 37895866
A novel osteolytic disorder due to mutation was discovered recently as early-onset Paget's disease of bone (PDB). Bone loss and pain in adult PDB patients have been treated using bisphosphonates....
10.
Hasegawa S, An J, Hino J, Amano Y, Nakagawa Y, Miyatake K, et al.
J Orthop Surg (Hong Kong) . 2023 Jun; 31(2):10225536231181708. PMID: 37272023
Background: Intra-articular injection of C-type natriuretic peptide (CNP) at the acute inflammatory stage suppressed fibrotic changes in the infrapatellar fat pad (IFP), articular cartilage degeneration, and persistent pain in a...